@article{313165ee4139421c8732fce2179fadaf,
title = "Reversal Agents for the New Generation of Oral Anticoagulants: Implications for the Perioperative Physician",
keywords = "activated charcoal, andexanet, apixaban, aripazine, atrial fibrillation, dabigatran, direct thrombin inhibitor, edoxaban, factor Xa, idarucizumab, novel oral anticoagulants, prothrombin complex concentrates, recombinant factor VIIa, rivaroxaban, vitamin K antagonists, warfarin",
author = "Lohrmann, {Graham M.} and Danish Atwal and Augoustides, {John G.} and Wajih Askar and Patel, {Prakash A.} and Kamrouz Ghadimi and Gerges Makar and Gutsche, {Jacob T.} and Shamoun, {Fadi E.} and Harish Ramakrishna",
year = "2016",
doi = "10.1053/j.jvca.2016.01.005",
language = "English (US)",
journal = "Journal of Cardiothoracic and Vascular Anesthesia",
issn = "1053-0770",
publisher = "W.B. Saunders Ltd",
}